ODFL Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Operational Performance EPAM Q1 2026 Earnings EPS Beats Estimates Modestly Amid Subdued Market Reaction Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings EPS Beat Narrowed Net Loss No Revenue Reported LSF Q1 2026 Earnings Massive EPS Surprise Defies Expectations DBX Q1 2026 Earnings EPS Beats Estimates by 8 Amid Modest Stock Uptick ATAI Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances